Skip to main content
. 2019 Oct 23;8(12):e1671762. doi: 10.1080/2162402X.2019.1671762

Table 1.

Characteristics of the 34 patients with NSCLC who were assessed for the presence of bone marrow- and peripheral blood-derived TA-reactive T cells using the ELISPOT analysis.

Variable n = 34
Sex  
  Male 18 (52.9%)
  Female 16 (47.1%)
Age, median years (range) 65 (40–83)
Smoking, median pack-years (range) 35 (0–90)
Operation type  
  Segmentectomy 2 (5.9%)
  Lobectomy
Bilobectomy
27 (79.4%)
3 (8.8%)
  Pneumonectomy 2 (5.9%)
Pathological stage  
  I 10 (29.4%)
  II 11 (32.4%)
  III 13 (38.2%)
Histological type  
  Adenocarcinoma 21 (61.8%)
  Squamous cell carcinoma 7 (20.6%)
  Large cell carcinoma 4 (11.8%)
  Adenosquamous carcinoma 2 (5.9%)
Lymphatic invasion  
  Negative 20 (58.8%)
  Positive 14 (41.2%)
Vascular invasion  
  Negative 18 (52.9%)
  Positive 16 (47.1%)
Visceral pleural invasion  
  Negative 23 (67.6%)
  Positive 11 (32.4%)